Contact: +91-9711224068
  • Printed Journal
  • Indexed Journal
  • Refereed Journal
  • Peer Reviewed Journal
International Journal of Medicine Sciences

Vol. 5, Issue 2, Part A (2023)

Role of bempedoic acid in lipid management-An Indian perspective


JP Sawhney and Peeyush Jain


In India, atherosclerotic heart disease is a primary cause of mortality and morbidity. Several hypolipidemic medications target low-density lipoprotein cholesterol (LDL-C) to reduce the risk of atherosclerosis. Statins remain the gold standard for dyslipidemia management. Despite the fact that lipid-lowering medicines, particularly statins, have demonstrated significant success in lowering the risk of cardiovascular disease (CVD), many patients fail to meet the lipid targets indicated by clinical recommendations. Bempedoic acid is a novel hypolipidemic agent that inhibits the adenosine triphosphate citrate lyase enzyme in the cholesterol production pathway. Results from the Cholesterol Lowering via Bempedoic Acid [ECT1002], an ACL-Inhibiting Regimen (CLEAR) trial have demonstrated that bempedoic acid added to maximally tolerated statin therapy provided long-term safety and efficacy. Bempedoic acid is a significant addition to the therapeutic options for individuals with high LDL-C. This article explores the perspectives of Indian experts on the role of bempedoic acid in lipid management.

Pages: 01-05  |  387 Views  135 Downloads

International Journal of Medicine Sciences
How to cite this article:
JP Sawhney and Peeyush Jain. Role of bempedoic acid in lipid management-An Indian perspective. Int. J. Med. Sci. 2023;5(2):01-05. DOI: 10.33545/26648881.2023.v5.i2a.36